Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis

Journal:
The Lancet Oncology
Published:
DOI:
10.1016/s1470-2045(25)00429-2
Affiliations:
15
Authors:
17
Go to article
Institutions Authors Share
Sant'Orsola Malpighi Hospital, Italy
4.833333
 0.28
University of Bologna (UNIBO), Italy
3.833333
 0.23
Dana-Farber Cancer Institute (DFCI), United States of America (USA)
1.833333
 0.11
University Hospital of Lausanne (CHUV), UNIL, Switzerland
1.000000
 0.06
The University of Texas MD Anderson Cancer Center, United States of America (USA)
1.000000
 0.06
Hospital Sírio-Libanês, Brazil
1.000000
 0.06
Harvard University, United States of America (USA)
1.000000
 0.06
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
1.000000
 0.06
The University of Chicago (UChicago), United States of America (USA)
1.000000
 0.06
University of Parma (UNIPR), Italy
0.500000
 0.03
Interested in Oncology and Carcinogenesis?